American Red Cross Blood Services Southwest Region FDA Inspection Record
American Red Cross Blood Services Southwest Region is an FDA-inspected facility (FEI 3006805687) located in Dallas, TX, US. RegDataLab tracks 8 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Jul 11, 2024: No Action Indicated (NAI)
- Inspections on record
- 8 (4 VAI, 4 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 5, latest Mar 4, 2024
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Jul 11, 2024 | No Action Indicated (NAI) | No citations listed |
| Jan 31, 2019 | Voluntary Action Indicated (VAI) | Following manufacturer's instructions (21 CFR 606.65(e)) |
| Jan 19, 2017 | No Action Indicated (NAI) | No citations listed |
| Oct 21, 2014 | No Action Indicated (NAI) | No citations listed |
| Jun 18, 2014 | Voluntary Action Indicated (VAI) | Following manufacturer's instructions (21 CFR 606.65(e)) Establish, maintain and follow manufacturing SOPs (21 CFR 606.100(b)) |
| Sep 19, 2013 | No Action Indicated (NAI) | No citations listed |
| Sep 24, 2012 | Voluntary Action Indicated (VAI) | Establish, maintain and follow manufacturing SOPs (21 CFR 606.100(b)) |
| Apr 5, 2010 | Voluntary Action Indicated (VAI) | Establish, maintain and follow manufacturing SOPs (21 CFR 606.100(b)) |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Mar 4, 2024 | Class III | B-0259-2025 | Red Blood Cells, Leukocytes Reduced Red Blood Cells, Leukocytes Reduced, which were not quarantined subsequent to receiving information regarding a post donation illness, were… |
| Dec 23, 2022 | Class III | B-0349-2023 | Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced Plateletpheresis products, which were not stored under continuous agitation, were distributed. |
| Aug 28, 2021 | Class II | B-0117-2022 | Red Blood Cells, Leukocytes Reduced, Irradiated Red Blood Cell, collected from a donor whose arm preparation was not performed in a manner that ensures sterility, was distributed. |
| Dec 11, 2018 | Class II | B-0309-2019 | Red Blood Cells, Leukocytes Reduced Blood product in which routine testing/testing performed, interpreted, documented, or labeled incorrectly, was distributed. |
| Mar 23, 2018 | Class III | B-0523-2018 | Blood and Blood Products for Reprocessing Blood product collected from a donor for whom donor suitability was not adequately determined, was distributed. |
FDA record score
4 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
6 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Jan 31, 2019 | 6 x 0.25 | 1.5 |
| Class II recall B-0117-2022, this FEI as the recalling firm | Aug 28, 2021 | 4 x 0.25 | 1 |
| Class II recall B-0309-2019, this FEI as the recalling firm | Dec 11, 2018 | 4 x 0.25 | 1 |
| Inspection classified VAI | Jun 18, 2014 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Sep 24, 2012 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Apr 5, 2010 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 17, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 17, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 17, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 17, 2026 | Newest record Nov 16, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing American Red Cross Blood Services Southwest Region as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check American Red Cross Blood Services Southwest Region yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- American Red Cross Blood Services Southwest Region
- Location
- Dallas, TX (US)
- Source
- inspections